1 / 33

CHAPTER 1 Overview Of Renal Biopsy In Malaysia Lee Ming Lee Lily Mushahar Lee Day Guat

CHAPTER 1 Overview Of Renal Biopsy In Malaysia Lee Ming Lee Lily Mushahar Lee Day Guat. Table 1.2.1: Total number of renal biopsies by centres, 2005 – 2012. 5 th MRRB report 2011 & 2012, Malaysia. Continue;. 5 th MRRB report 2011 & 2012, Malaysia.

brennan-matthews
Download Presentation

CHAPTER 1 Overview Of Renal Biopsy In Malaysia Lee Ming Lee Lily Mushahar Lee Day Guat

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CHAPTER 1Overview Of Renal Biopsy In MalaysiaLee Ming LeeLily MushaharLee Day Guat

  2. Table 1.2.1: Total number of renal biopsies by centres, 2005 – 2012 5th MRRB report 2011 & 2012, Malaysia

  3. Continue; 5th MRRB report 2011 & 2012, Malaysia

  4. Table 1.2.2: Distribution of reported native and graft renal biopsies by centre, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  5. Continue; 5th MRRB report 2011 & 2012, Malaysia

  6. Table 1.2.3(a): Distribution of native renal biopsy in patients by number of episodes, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  7. Table 1.2.3(b): Distribution of renal allograft biopsy in patients by number of episodes, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  8. Table 1.2.4.1(a): Age distribution of native renal biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  9. Table 1.2.4.1(b): Age distribution of renal allograft biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  10. Table 1.2.4.1(c): Age group distribution of reported renal biopsies by state, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  11. Table 1.2.4.2(a): Gender distribution of native renal biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  12. Table 1.2.4.2(b): Gender distribution of renal allograft biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  13. Table 1.2.4.3(a): Racial distribution of native renal biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  14. Table 1.2.4.3(b): Racial distribution of renal allograft biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  15. Table 1.2.5: Number of glomeruli obtained at each biopsy by centres, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  16. Continue; 5th MRRB report 2011 & 2012, Malaysia

  17. Table 1.2.6: Distribution of biopsy specimens to histopathology laboratories by participating centres, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  18. Continue; 5th MRRB report 2011 & 2012, Malaysia

  19. Continue; 5th MRRB report 2011 & 2012, Malaysia

  20. Figure 1.2.6(b) i: Distribution of biopsy specimens to Local histopathology laboratories by participating centres, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  21. Figure 1.2.6(b) ii: Distribution of biopsy specimens to Outside histopathology laboratories by participating centres, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  22. Table 1.2.6(c): Summary of biopsies received by local and outside laboratories, 2007-2010 5th MRRB report 2011 & 2012, Malaysia

  23. Table 1.2.6(d): Histopathology laboratories receiving renal biopsy specimens, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  24. Table 1.3.1(a): Indications for native renal biopsies, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  25. Table 1.3.1(b): Renal function at time of biopsy, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  26. Table 1.3.2: Histopathology of all native renal biopsies, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  27. Continue; 5th MRRB report 2011 & 2012, Malaysia

  28. Table 1.3.3.1: HPE diagnosis in patients presenting with Nephrotic Syndrome, 2005-2012 *Patients may have either one or more histopathology or not have any histopathology Others = Tubulo. Disease + Vascular + Advance GN + Others + Hereditary (no observation) 5th MRRB report 2011 & 2012, Malaysia

  29. Table 1.3.3.2: HPE diagnosis in Patients presenting with Asymptomatic Urine Abnormalities, 2005-2012 * Patients may have either one or more histopathology or not have any histopathology Others = Tubulo. Disease + Vascular + Advance GN + Others + Hereditary 5th MRRB report 2011 & 2012, Malaysia

  30. Table 1.3.3.3: HPE diagnosis in patients presenting with Nephritic-Nephrotic, 2005-2012 * Patients may have either one or more histopathology or not have any histopathology Others = Tubulo. Disease + Vascular + Advance GN + Others + Hereditary (no observation) 5th MRRB report 2011 & 2012, Malaysia

  31. Table 1.3.3.4: HPE diagnosis in Patients presenting with Nephritic syndrome, 2005-2012 * Patients may have either one or more histopathology or not have any histopathology Others = Tubulo. Disease + Vascular + Advance GN + Others + Hereditary 5th MRRB report 2011 & 2012, Malaysia

  32. Table 1.3.3.5: Table for Primary Glomerulonephritis, 2005-2012 5th MRRB report 2011 & 2012, Malaysia

  33. Figure 1.3.3.5: Primary gromerulonephritis according to the various age group, 2005-2012 Minimal change disease FSGS Ig A Nephropathy Membranous nephropathy Mesangial proliferative Non-Ig A Membrano proliferative Crescentic ANCA Idiopathic crescentic Not available/Missing 100% 90% 80% 70% 60% Percentage (%) 50% 40% 30% 20% 10% 0% <15 15-<25 25-<35 35-<45 45-<55 55-<65 >65 Age 5th MRRB report 2011 & 2012, Malaysia

More Related